⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LEGN News
Legend Biotech Corporation American Depositary Shares
CAR T-cell Therapy for NHL Clinical Trial Landscape Expands: Over 70 Companies Advancing Next-Generation Therapies | DelveInsight
globenewswire.com
NVS
ALLO
LEGN
CBIO
MBIO
CRSP
INCY
IMPP
SANA
VOR
CARG
AUTL
ARCL
LYEL
PRE
BEAM
CART
TAK
AZN
MRK
BMY
GEN
DGX
GMAB
ABBV
RLGT
CRGO
JNJ
GILD
JAZZ
SYBX
CASI
ATRA
SHEN
BIIB
VREX
Legend Biotech to Present Updated Long-Term and Real-World Evidence from CARVYKTI Clinical Program at the International Myeloma Society Annual Meeting
globenewswire.com
LEGN
Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference
globenewswire.com
LEGN
Legend Biotech Reports Second Quarter 2026 Results and Recent Highlights
globenewswire.com
LEGN
Legend Biotech to Host Investor Conference Call on Second Quarter 2026 Results
globenewswire.com
LEGN
Legend Biotech Announces CEO Transition
globenewswire.com
LEGN
Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors
globenewswire.com
CLDI
LEGN
RARE
Legend Biotech Corporation Announces Pricing of Public Offering
globenewswire.com
LEGN
Legend Biotech Corporation Announces Proposed Public Offering
globenewswire.com
LEGN
Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
globenewswire.com
LEGN